The Carboxyl-terminal Domain(111–165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency
Authors:
- Lea T. BerleauLBLea T. Berleau
- Hung V. NguyenHNHung V. Nguyen
- Helen ChenHCHelen Chen
- Henry HeinsohnHHHenry Heinsohn
- Richard VandlenRVRichard Vandlen
- Napoleone FerraraNFNapoleone Ferrara
Open Access
- 1 March 1996
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 271 (13) , 7788-7795
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Variations in the Size and Sulfation of Heparin Modulate the Effect of Heparin on the Binding of VEGF165 to Its ReceptorsBiochemical and Biophysical Research Communications, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells.Journal of Clinical Investigation, 1993
- Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences.Journal of Cell Biology, 1992
- 8 Growth Factor-Regulated Proteases and Extracellular Matrix Remodeling during Mammalian Development1990
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989
- Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta.Journal of Cell Biology, 1989
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific ActivityNature, 1962